Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groups.
Recommended vaccines
at-risk groups
determinants
vaccination coverage
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
01 09 2020
01 09 2020
Historique:
pubmed:
3
7
2020
medline:
22
6
2021
entrez:
3
7
2020
Statut:
ppublish
Résumé
Upon exposure to vaccine-preventable diseases, certain individuals are at increased risk for complications due to preexisting diseases, age or immunosuppressive treatment. Vaccination against influenza, pneumococcal disease and hepatitis B (for some groups) is advised in addition to standard vaccination against diphtheria, tetanus and pertussis. We estimated the vaccination coverage and determinants of recommended vaccinations in patients with diabetes mellitus type 1 (n = 173) and type 2 (n = 177), chronic kidney disease (CKD) (n = 138), heart failure (n = 200), chronic obstructive pulmonary disease (COPD) (n = 187), HIV (n = 201) or solid organ transplantation (SOT) (n = 201) in a monocentric study. Vaccination data were retrieved from documents provided by patients and general practitioners, and from the Flemish vaccination register. Less than 10% had received all recommended vaccines. Overall, 29% of subjects were vaccinated against diphtheria-tetanus, 10% against pertussis, 44% against influenza, 32% against pneumococcal disease and 24% of HIV patients and 31% of CKD patients against hepatitis B. Age was positively associated with vaccination against influenza (OR:2.0,
Identifiants
pubmed: 32614656
doi: 10.1080/21645515.2020.1763739
pmc: PMC7553698
doi:
Substances chimiques
Influenza Vaccines
0
Pneumococcal Vaccines
0
Tetanus Toxoid
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2136-2143Références
PLoS One. 2012;7(11):e50553
pubmed: 23226312
Eur Respir J. 2019 May 18;53(5):
pubmed: 30846476
Vaccine. 2016 Dec 20;34(52):6681-6690
pubmed: 27876197
Vaccine. 2018 Mar 7;36(11):1509-1515
pubmed: 29287678
Diabetes Res Clin Pract. 1991 Apr;12(1):61-8
pubmed: 1906798
Open Forum Infect Dis. 2014 May 27;1(1):ofu024
pubmed: 25734097
BMC Public Health. 2014 May 12;14:442
pubmed: 24884433
Vaccine. 2012 Jul 27;30(35):5222-8
pubmed: 22721901
Int J Chron Obstruct Pulmon Dis. 2019 Nov 15;14:2527-2533
pubmed: 31814718
Eur J Public Health. 2012 Aug;22(4):562-8
pubmed: 21750011
Vaccine. 2018 Jan 25;36(4):442-452
pubmed: 29287683
Heart Fail Rev. 2017 May;22(3):329-336
pubmed: 28508293
J Infect. 2012 Jul;65(1):17-24
pubmed: 22394683
Eur Respir J. 2010 Jun;35(6):1209-15
pubmed: 20513910
Am J Infect Control. 2018 Jan;46(1):e9-e11
pubmed: 29167031
Vaccine. 2016 Jul 12;34(32):3657-62
pubmed: 27255466
Kidney Int. 2005 Jun;67(6):2089-100
pubmed: 15882252
Am J Infect Control. 2020 Mar;48(3):290-296
pubmed: 31630922
Prim Care Diabetes. 2020 Aug;14(4):343-348
pubmed: 31582202
Euro Surveill. 2019 Jul;24(29):
pubmed: 31339099
Prev Med Rep. 2018 Oct 19;12:284-293
pubmed: 30406006
Diabetes Care. 1990 Aug;13(8):876-82
pubmed: 2209323
Vaccine. 2013 Mar 15;31(12):1560-8
pubmed: 23196207
BMC Med. 2015 Mar 17;13:53
pubmed: 25857236
Circulation. 2019 Jan 29;139(5):575-586
pubmed: 30586760
Am J Obstet Gynecol. 2016 May;214(5):617.e1-7
pubmed: 26627727